PARTIAL
Phase NA Recruiting
600 enrolled
Intermittent Fasting in Prostate Cancer Patients Receiving Androgen Deprivation Therapy
Phase NA Recruiting
30 enrolled
EMUPRO
Recruiting
2,000 enrolled
Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer
Phase 1/2 Recruiting
52 enrolled
DIVINE
Phase 2 Recruiting
532 enrolled
177^Lu-PSMA-617 in Combination With Sipuleucel-T for the Treatment of Metastatic Castration-Resistant Prostate Cancer
Phase 1 Recruiting
30 enrolled
Outcomes of Focal Ablation for Prostate Cancer
Recruiting
225 enrolled
Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer
Phase 2 Recruiting
48 enrolled
Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion and Non-Contrast MRI
Recruiting
1,000 enrolled
PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer
Phase 2 Recruiting
54 enrolled
SURV-QoL
Phase NA Recruiting
200 enrolled
CLIQQC
Recruiting
2,000 enrolled
HIFU for Focal Ablation of Prostate Tissue: An Observational Study
Recruiting
100 enrolled
Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability Testing
Recruiting
45 enrolled
Tumor Genomic Pre-test Counseling Tool for Black or African-American Men With Prostate Cancer
Phase NA Recruiting
80 enrolled
A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate Cancer
Phase 2 Recruiting
57 enrolled
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
Phase NA Recruiting
40 enrolled
MAGIC
Recruiting
222 enrolled
Green Tea and Quercetin in Combination With Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Patients
Phase 1/2 Recruiting
99 enrolled
ASpiRE
Phase 1/2 Recruiting
78 enrolled
A Study of Tarlatamab for People With Prostate Cancer
Phase 2 Recruiting
32 enrolled
Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer
Phase 2 Recruiting
140 enrolled
DEPICT
Recruiting
1,000 enrolled
Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation
Phase NA Recruiting
120 enrolled
FASN
Phase 2 Recruiting
50 enrolled
UPLIFT
Phase 1/2 Recruiting
30 enrolled
ReRT
Phase NA Recruiting
1,800 enrolled
MUSIC-AS
Phase NA Recruiting
210 enrolled
WOMBAT
Phase 2 Recruiting
69 enrolled
Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer
Phase 1/2 Recruiting
39 enrolled
Multimodal Telerehabilitation of Rural Patients With Advanced Prostate Cancer
Phase NA Recruiting
30 enrolled
POSLUMA® (18F-rhPSMA-7.3) PET-CT for PIRADS 2/3 Lesions
Phase 2 Recruiting
30 enrolled
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
Phase NA Recruiting
300 enrolled
EMERHIT
Phase NA Recruiting
346 enrolled
MPE-RP
Phase NA Recruiting
78 enrolled
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery
Phase NA Recruiting
224 enrolled
Cleveland African American Prostate Cancer Project
Phase NA Recruiting
800 enrolled
Creatine Supplementation and Resistance Training to Improve Sarcopenia Parameters in Patients With Prostate Cancer After Androgen Deprivation Therapy
Phase NA Recruiting
34 enrolled
PPSARP
Recruiting
500 enrolled
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recruiting
2,000 enrolled
RARP EI
Recruiting
200 enrolled
PREDICT
Phase 2 Recruiting
474 enrolled
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Phase 3 Recruiting
1,260 enrolled
Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostate Cancer Survivors
Phase NA Recruiting
50 enrolled
Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer
Phase NA Recruiting
50 enrolled
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 Recruiting
1,209 enrolled
Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC)
Phase 1/2 Recruiting
30 enrolled
TerbinaPro
Phase 2 Recruiting
42 enrolled
Using a mHealth App to Improve Quality-of-Life Outcomes in Black Prostate Cancer Survivors
Phase NA Recruiting
248 enrolled
MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial
Phase NA Recruiting
1,750 enrolled